Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression
- PMID: 9622084
Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression
Abstract
Administration of recombinant interleukin 12 (IL-12) induces tumor regression that is associated with T-cell infiltration in the OV-HM ovarian carcinoma and CSA1M fibrosarcoma models. After confirming the blocking of regression by injection of anti-IFN-gamma monoclonal antibody (mAb), we investigated the mechanisms underlying the requirement of IFN-gamma in T-cell migration and tumor regression. T-cell migration was inhibited by injection of anti-IFN-gamma mAb to OV-HM tumor-bearing mice prior to IL-12 treatment. We examined, using the lymphoid cell migration assay, whether IFN-gamma is required for enhancing the migratory capacity of T cells or the T cell-accepting potential of tumor masses during IL-12 treatment. Spleen cells from IL-12-treated or untreated OV-HM-bearing mice were stained in vitro with a fluorescein chemical and transferred i.v. into OV-HM-bearing mice that were not treated with IL-12. Migration of donor cells was quantitated by counting the number of fluorescent cells on cryostat sections of tumor masses from recipient mice. Compared to spleen cells from OV-HM-bearing mice that were not treated with IL-12, enhanced migration was observed for cells from IL-12-treated OV-HM-bearing mice. Anti-IFN-gamma pretreatment of donor mice before IL-12 treatment did not reduce the migratory capacity of T cells, whereas migration was markedly inhibited in recipient mice injected with anti-IFN-gamma. Anti-IFN-gamma pretreatment decreased vascular cell adhesion molecule-1 (VCAM-1)-/intercellular adhesion molecule-1 (ICAM-1)-positive blood vessels at tumor sites. Consistent with this, migration was also inhibited by treatment of recipient mice with either anti-VCAM-1 or anti-ICAM-1 mAb. In contrast to the OV-HM model, T-cell migration was not affected in the CSA1M model following preinjection of anti-IFN-gamma mAb. In this model, VCAM-1-/ICAM-1-positive blood vessels existed even after anti-IFN-gamma treatment, although tumor regression was completely inhibited. These results indicate that IFN-gamma plays two distinct roles in expressing the antitumor efficacy of IL-12: one is to support the T-cell acceptability of tumor masses, and the other is to mediate the antitumor effects of migrated T cells.
Similar articles
-
A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression.Cancer Res. 1999 Apr 1;59(7):1531-8. Cancer Res. 1999. PMID: 10197625
-
A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.Cancer Res. 2002 Jul 1;62(13):3751-8. Cancer Res. 2002. PMID: 12097285
-
Administration of IL-12 induces a CD3+ CD4- CD8- B220+ lymphoid population capable of eliciting cytolysis against Fas-positive tumor cells.J Immunol. 1997 Sep 15;159(6):2599-605. J Immunol. 1997. PMID: 9300678
-
[The potential of interleukin-12 for use in cancer therapy].Gan To Kagaku Ryoho. 1996 Jul;23(8):961-71. Gan To Kagaku Ryoho. 1996. PMID: 8687231 Review. Japanese.
-
Interleukin-12: potential role in cancer therapy.Important Adv Oncol. 1995:3-18. Important Adv Oncol. 1995. PMID: 7672811 Review.
Cited by
-
IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance.Cancers (Basel). 2024 Jul 27;16(15):2676. doi: 10.3390/cancers16152676. Cancers (Basel). 2024. PMID: 39123403 Free PMC article. Review.
-
Anti-tumour effects of polysaccharide extracted from Acanthopanax senticosus and cell-mediated immunity.Exp Ther Med. 2018 Feb;15(2):1694-1701. doi: 10.3892/etm.2017.5568. Epub 2017 Nov 27. Exp Ther Med. 2018. PMID: 29434755 Free PMC article.
-
Gene expression profiling in undifferentiated thyroid carcinoma induced by high-dose radiation.J Radiat Res. 2016 Jun;57(3):238-49. doi: 10.1093/jrr/rrw002. Epub 2016 Mar 22. J Radiat Res. 2016. PMID: 27006382 Free PMC article.
-
Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model.Mol Cancer. 2013 Nov 12;12(1):136. doi: 10.1186/1476-4598-12-136. Mol Cancer. 2013. PMID: 24219565 Free PMC article.
-
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts.Cancer Res. 2010 Sep 1;70(17):6725-34. doi: 10.1158/0008-5472.CAN-10-0735. Epub 2010 Jul 20. Cancer Res. 2010. PMID: 20647327 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous